Evidence map›Paper›PMID 28367308›Full record

ArticleBiology of sex differences2017

Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences.

Laura Zielinski, Meha Bhatt, Nitika Sanger, Carolyn Plater, Andrew Worster, Michael Varenbut, Jeff Daiter, Guillaume Pare, David C Marsh, Dipika Desai and 5 more

Open access · goldAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Biology of sex differences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Laura ZielinskiMiNDS Neuroscience Graduate Program, McMaster University, Hamilton, ON Canada.
Meha BhattHealth Research Methodology Graduate Program, McMaster University, Hamilton, ON Canada.
Nitika SangerMedical Science Graduate Program, McMaster University, Hamilton, ON Canada.
Carolyn PlaterCanadian Addiction Treatment Centres, Hamilton, ON Canada.
Andrew WorsterCanadian Addiction Treatment Centres, Hamilton, ON Canada.
Michael VarenbutCanadian Addiction Treatment Centres, Hamilton, ON Canada.
Jeff DaiterCanadian Addiction Treatment Centres, Hamilton, ON Canada.
Guillaume ParePopulation Genomics Program, Chanchlani Research Centre, McMaster University, Hamilton, ON Canada.
David C MarshCanadian Addiction Treatment Centres, Hamilton, ON Canada.
Dipika DesaiPopulation Genomics Program, Chanchlani Research Centre, McMaster University, Hamilton, ON Canada.
James MacKillopDepartment of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON Canada.
Meir SteinerDepartment of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON Canada.
Stephanie McDermid VazDepartment of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON Canada.
Lehana ThabaneDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON Canada.
Zainab SamaanPopulation Genomics Program, Chanchlani Research Centre, McMaster University, Hamilton, ON Canada.
McMaster University · CACentre for Addiction and Mental Health · CAPopulation Health Research Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCannabis will soon become legalized in Canada, and it is currently unclear how this will impact public health. Methadone maintenance treatment (MMT) is the most common pharmacological treatment for opioid use disorder (OUD), and despite its documented effectiveness, a large number of patients respond poorly and experience relapse to illicit opioids. Some studies implicate cannabis use as a risk factor for poor MMT response. Although it is well established that substance-use behaviors differ by sex, few of these studies have considered sex as a potential moderator. The current study aims to investigate sex differences in the association between cannabis use and illicit opioid use in a cohort of MMT patients.

methodsThis multicentre study recruited participants on MMT for OUD from Canadian Addiction Treatment Centre sites in Ontario, Canada. Sex differences in the association between any cannabis use and illicit opioid use were investigated using multivariable logistic regression. A secondary analysis was conducted to investigate the association with heaviness of cannabis use.

resultsThe study included 414 men and 363 women with OUD receiving MMT. Cannabis use was significantly associated with illicit opioid use in women only (OR = 1.82, 95% CI 1.18, 2.82,

conclusionsThis is the largest study to date examining the association between cannabis use and illicit opioid use. Cannabis use may be a sex-specific predictor of poor response to MMT, such that women are more likely to use illicit opioids if they also use cannabis during treatment. Women may show improved treatment outcomes if cannabis use is addressed during MMT.

Indexed as

Opiate Substitution TreatmentAdolescentAdultAgedCannabisFemaleHumansMaleMarijuana SmokingMethadoneMiddle AgedOntarioOpioid-Related DisordersSex CharacteristicsYoung AdultMethadoneCannabisMethadone maintenance treatmentOpioidOpioid use disorderSex differences

Identifiers

PMID28367308
PMCPMC5372283
OpenAlexW2605108748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.